Register entry
- Registered sites
- 0
- Active NDC listings
- 3
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
33 active NDC listings: 3 human prescription drug. By marketing category: ANDA 3.
| Dosage form | NDCs |
|---|---|
| capsule | 3 |
| Route | NDCs |
|---|---|
| oral | 3 |
| Labeller name on the listing | NDCs |
|---|---|
| mylaninstitutional inc. | 3 |
Catalogue
Marketed products
3| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Tacrolimus | Tacrolimus | capsule, oral | 51079-028ANDA |
| Tacrolimus | Tacrolimus | capsule, oral | 51079-817ANDA |
| Tacrolimus | Tacrolimus | capsule, oral | 51079-818ANDA |
Compare
Other companies listing tacrolimus
- Cardinal Health 418, Inc.34 sites · 833 NDC
- Dr. Reddy's Laboratories Limited15 sites · 683 NDC
- Glenmark Pharmaceuticals Inc., USA9 sites · 383 NDC
- Biocon Biologics Limited9 sites · 176 NDC
- Astellas Pharma US, Inc.8 sites · 40 NDC
- Pharma Packaging Solutions, LLC dba Tjoapack, LLC5 sites · 667 NDC
- Sandoz Industrial Products S.A5 sites · 441 NDC
- Strides Pharma Science Limited5 sites · 230 NDC
- International Medication Systems, Ltd.3 sites · 2,801 NDC
- Safecor Health, LLC3 sites · 103 NDC
Enquiry
Common questions
- Is MylanInstitutional Inc. FDA approved?
- MylanInstitutional Inc. holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does MylanInstitutional Inc. make?
- 3 products are listed under MylanInstitutional Inc. in the openFDA NDC Directory, most often as capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.